We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
3 own
2 watching
Current Price
$1.34
$-0.02
(-1.47%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
40.96M
52-Week High
14.5
52-Week Low
1.31
Average Volume
0.5M
Dividend Yield
--
P/E Ratio
--
Market Capitalization40.96M
52-Week High14.5
52-Week Low1.31
Average Volume0.5M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
9days ago
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Ticker Report
1month ago
SVB Leerink cut shares of Immunic (NASDAQ:IMUX Get Rating) from an outperform rating to a market perform rating in a research report report published on Friday, MarketBeat reports. SVB Leerink currently has $5.00 price target on the stock. A number of other analysts have also commented on ...
PR Newswire
1month ago
Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? PR Newswire NEW YORK, Oct. 24, 2022 NEW YORK, Oct. 24, 2022...
PR Newswire
1month ago
Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
PR Newswire
1month ago
Thinking about buying stock in Senti Biosciences, Green Giant, Vuzix, Immunic, or Crown Electrokinetics? Thinking about buying stock in Senti Biosciences, Green Giant, Vuzix, Immunic, or Crown Electrokinetics? PR Newswire NEW YORK, Oct. 10, 2022 NEW YORK, Oct. 10, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$1.34
$-0.02
(-1.47%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00